1. Brocchi E, Tomassetti P, Misitano B et al. Endoscopic markers in adult coeliac disease. Dig Liver Dis 2002; 34: 177–82.
2. Cammarota G, Gasbarrini A, Gasbarrini G. No more biopsy in the diagnostic work-up of celiac disease. Gastrointest Endosc 2005; 62: 119–21.
3. European Society for Pediatric Gastroenterology,Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease. JPGN 2012; 54: 136–60.
4. Marsh MN. Mucosal pathology in gluten sensitivity. In: Michael N Marsh, editor. Coeliac Disease. Oxford: Blackwell Scientific Publications, 1992: 136–91.
5. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11 (10): 1185–94.
6. Brown I, Mino-Kenudson M., Deshpande V et al. Intraepithelial Lymphocytosis in Architecturally Preserved Proximal Small Intestinal Mucosa: An Increasing Diagnostic Problem With a Wide Differential Diagnosis. Arch Pathol Lab Med 2006; 130 (7): 1020–5.
7. Koskinen O, Collin P, Korponay-Szabo I et al. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease. J Pediatr Gastroenterol Nutr 2008; 47 (4): 436–42.
8. Dahlbom I. Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis by Quantification of IgA/IgG Serum Antibodies to Tissue Transglutaminase. J Pediatr Gastroenterol Nutr 2010; 50 (Issue 2); 140–6.
9. Ferrara F, Quaglia S, Caputo I et al. Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. Clin Exp Immunol 2010; 159 (Issue 2): 217–23.
10. Peracchi M, Trovato C, Longhi M et al. Tissue transglutaminase antibodies in patients with end-stage heart failure. Am J Gastroenterol 2002; 97: 2850–4.
11. Shamaly H et al. Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome. J Pediatr Gastroenterol Nutr 2007; 44 (5): 583–6.
12. Hill ID, Dirks MH, Liptak GS et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol 2005; 40: 1–19.
13. Prince HE. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol 2006; 13: 150–1.
14. Lewis N, Scott B. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010; 31 (1): 73–81.
15. Meuwisse GW. Diagnostic criteria in coeliac disease. Acta Paediatr Scand 1970; 59: 461–3.
16. McNeish AS, Harms K, Rey J et al. Re-evaluation of diagnostic criteria for celiac disease. Arch Dis Child 1979; 54: 783–6.
17. Guandalini S, Ventura A, Ansaldi N et al. Diagnosis of coeliac disease: time for a change? Arch Dis Child 1989; 64: 1320–5.
18. Revised criteria for diagnosis of celiac disease. Report of working group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Arch Disase Childhood 1990; 65: 909–11.
21. Shewry PR, Napier JA, Tatham AS. Seed storage proteins: structures and biosynthesis. Plant Cell 1995; 7: 945–56.
22. Pulido OM, Gillespie Z, Zarkadas M et al. Introduction of oats in the diet of individuals with celiac disease: a systematic review. In Steve L. Taylor, ed.: advances in food and nutritional research, vol. 57. Burlington: Academic press, 2009.
23. Frisoni M, Corazza GR, Lafiandra D et al. Wheat deficient in gliadins: promising tool for treatment of coeliac disease. Gut 1995; 36: 375–8.
24. Spaenij-Dekking L, Kooy-Winkelaar Y, van Veelen P et al. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 2005; 129: 797–806.
25. Rizello CG, De Angelis MD, Di Cagno R et al. Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease. Appl Environ Microb 2007; 73: 4499–507.
26. Maiuri L, Ciacci C, Ricciardelli I et al. Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology 2005; 129: 1400–13.
27. Benahmed M, Meresse B, Arnulf B et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2007; 132: 994–1008.

И.Н.Захарова1, Т.Э.Боровик2, Е.А.Рославцева2, Ю.А.Дмитриева1, Е.Н.Касаткина3, В.А.Курьянинова4, Ф.С.Дзебисова1

1 ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России, Москва;
2 ФГБНУ Научный центр здоровья детей, Москва;
3 ГБУЗ «ДГКБ им. З.А.Башляевой ДЗМ» (Тушинская детская больница), Москва
4 ГБОУ ВПО Ставропольский государственный медицинский университет Минздрава России